BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 20810500)

  • 1. The LupusQoL and associations with demographics and clinical measurements in patients with systemic lupus erythematosus.
    McElhone K; Castelino M; Abbott J; Bruce IN; Ahmad Y; Shelmerdine J; Peers K; Isenberg D; Ferenkeh-Koroma A; Griffiths B; Akil M; Maddison P; Gordon C; Teh LS
    J Rheumatol; 2010 Nov; 37(11):2273-9. PubMed ID: 20810500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is there an advantage over SF-36 with a quality of life measure that is specific to systemic lupus erythematosus?
    Touma Z; Gladman DD; Ibañez D; Urowitz MB
    J Rheumatol; 2011 Sep; 38(9):1898-905. PubMed ID: 21724700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective study.
    Mok CC; Ho LY; Cheung MY; Yu KL; To CH
    Scand J Rheumatol; 2009; 38(2):121-7. PubMed ID: 18991189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a disease-specific health-related quality of life measure, the LupusQol, for adults with systemic lupus erythematosus.
    McElhone K; Abbott J; Shelmerdine J; Bruce IN; Ahmad Y; Gordon C; Peers K; Isenberg D; Ferenkeh-Koroma A; Griffiths B; Akil M; Maddison P; Teh LS
    Arthritis Rheum; 2007 Aug; 57(6):972-9. PubMed ID: 17665467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Rheumatology Attitudes Index and its helplessness subscale are valid and reliable measures of learned helplessness in Asian patients with systemic lupus erythematosus.
    Thumboo J; Fong KY; Chan SP; Leong KH; Feng PH; Thio ST; Boey ML
    J Rheumatol; 1999 Jul; 26(7):1512-7. PubMed ID: 10405938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An exploration of patient-reported symptoms in systemic lupus erythematosus and the relationship to health-related quality of life.
    Pettersson S; Lövgren M; Eriksson LE; Moberg C; Svenungsson E; Gunnarsson I; Welin Henriksson E
    Scand J Rheumatol; 2012 Oct; 41(5):383-90. PubMed ID: 22646821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health related quality of life in Mexican women with systemic lupus erythematosus: a descriptive study using SF-36 and LupusQoL(C).
    García-Carrasco M; Mendoza-Pinto C; Cardiel MH; Méndez-Martínez S; García-Villaseñor A; Jiménez-Hernández C; Alonso-García NE; Briones-Rojas R; Ramos-Álvarez G; López-Colombo A
    Lupus; 2012 Oct; 21(11):1219-24. PubMed ID: 22875651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consistency and validity of patient administered assessment of quality of life by the MOS SF-36; its association with disease activity and damage in patients with systemic lupus erythematosus.
    Stoll T; Gordon C; Seifert B; Richardson K; Malik J; Bacon PA; Isenberg DA
    J Rheumatol; 1997 Aug; 24(8):1608-14. PubMed ID: 9263159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of a disease-specific health-related quality of life measure in adult Italian patients with systemic lupus erythematosus: LupusQoL-IT.
    Conti F; Perricone C; Reboldi G; Gawlicki M; Bartosiewicz I; Pacucci VA; Massaro L; Miranda F; Truglia S; Alessandri C; Spinelli FR; Teh LS; Ceccarelli F; Valesini G
    Lupus; 2014 Jul; 23(8):743-51. PubMed ID: 24569393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Learning from discordance in patient and physician global assessments of systemic lupus erythematosus disease activity.
    Neville C; Clarke AE; Joseph L; Belisle P; Ferland D; Fortin PR
    J Rheumatol; 2000 Mar; 27(3):675-9. PubMed ID: 10743807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health-related quality of life assessed by LupusQoL questionnaire and SF-36 in Turkish patients with systemic lupus erythematosus.
    Yilmaz-Oner S; Oner C; Dogukan FM; Moses TF; Demir K; Tekayev N; Atagunduz P; Tuglular S; Direskeneli H
    Clin Rheumatol; 2016 Mar; 35(3):617-22. PubMed ID: 25846834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LupusQoL-FR is valid to assess quality of life in patients with systemic lupus erythematosus.
    Devilliers H; Amoura Z; Besancenot JF; Bonnotte B; Pasquali JL; Wahl D; Maurier F; Kaminsky P; Pennaforte JL; Magy-Bertrand N; Arnaud L; Binquet C; Guillemin F
    Rheumatology (Oxford); 2012 Oct; 51(10):1906-15. PubMed ID: 22826305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validity and reliability of the Lupus QoL index in Turkish systemic lupus erythematosus patients.
    Pamuk ON; Onat AM; Donmez S; Mengüs C; Kisacik B
    Lupus; 2015 Jul; 24(8):816-21. PubMed ID: 25542903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related quality of life in portuguese SLE patients: an outcome measure independent of disease activity and cumulative damage.
    Duarte C; Abreu P; Couto M; Vaz C; Malcata A; Inês L
    Acta Reumatol Port; 2010; 35(1):30-5. PubMed ID: 20518146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associates of health status in patients with systemic lupus erythematosus.
    Sutcliffe N; Clarke AE; Levinton C; Frost C; Gordon C; Isenberg DA
    J Rheumatol; 1999 Nov; 26(11):2352-6. PubMed ID: 10555890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome measures to be used in clinical trials in systemic lupus erythematosus.
    Strand V; Gladman D; Isenberg D; Petri M; Smolen J; Tugwell P
    J Rheumatol; 1999 Feb; 26(2):490-7. PubMed ID: 9972993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construct and criterion validity of the short form-6D utility measure in patients with systemic lupus erythematosus.
    Harrison MJ; Ahmad Y; Haque S; Dale N; Teh LS; Snowden N; Ho P; Gorodkin R; Bruce IN
    J Rheumatol; 2012 Apr; 39(4):735-42. PubMed ID: 22298908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibromyalgia is a major contributor to quality of life in lupus.
    Gladman DD; Urowitz MB; Gough J; MacKinnon A
    J Rheumatol; 1997 Nov; 24(11):2145-8. PubMed ID: 9375874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired health status and the effect of pain and fatigue on functioning in clinical trial patients with systemic lupus erythematosus.
    Petri M; Kawata AK; Fernandes AW; Gajria K; Greth W; Hareendran A; Ethgen D
    J Rheumatol; 2013 Nov; 40(11):1865-74. PubMed ID: 24085548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcome of early neuropsychiatric events due to active disease in systemic lupus erythematosus.
    Wang M; Gladman DD; Ibañez D; Urowitz MB
    Arthritis Care Res (Hoboken); 2012 Jun; 64(6):833-7. PubMed ID: 22290935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.